Concepedia

Wensheng Li

WL

Statistics

Publications

11

Citations

315

H-Index

10

Active since

2017

Affiliations

First Affiliated Hospital of Henan University of Science and Technology(Current)

Shandong First Medical University

Yidu Central Hospital of Weifang

Shenzhen University

Wensheng Li is an author at First Affiliated Hospital of Henan University of Science and Technology specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2017–2024

11

Publications

11

ZEB1 activated-VPS9D1-AS1 promotes the tumorigenesis and progression of prostate cancer by sponging miR-4739 to upregulate MEF2D

Xiaobin Wang, Qiangjun Chen, Xi Wang et al. · Biomedicine & Pharmacotherapy · 2019 · 57 citations · Full text

, , +17

Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis

Weifeng Liu, Xinshuai Wang, Junjun Sun et al. · OncoTargets and Therapy · 2017 · 53 citations · Full text

, , +17

Long noncoding RNA BDNF-AS is associated with clinical outcomes and has functional role in human prostate cancer

Wensheng Li, Zhongling Dou, Shuguang We et al. · Biomedicine & Pharmacotherapy · 2018 · 41 citations

, , +14

Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma

Xiaobin Wang, Xi Wang, Zhiyi Zhu et al. · Biomedicine & Pharmacotherapy · 2019 · 31 citations · Full text

, , +17

Dual delivery nanoscale device for miR-451 and adriamycin co-delivery to combat multidrug resistant in bladder cancer

Shuguang Wei, Jiannan Gao, Maopeng Zhang et al. · Biomedicine & Pharmacotherapy · 2019 · 30 citations · Full text

, , +17

1–5 of 11